SCHEMBL21628709

SCHEMBL21628709

O=C(O)c1cnc(Oc2ccc(C(F)(F)C(F)(F)C(F)(F)F)cc2)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 8/20 0.43
SMN1; SMN2 Q16637 2/20 0.39
PTGER2 P43116 2/20 0.36
PPARG P37231 2/20 0.36
LTA4H P09960 2/20 0.35
KCNH2 Q12809 1/20 0.35
SCN9A Q15858 1/20 0.35
MRGPRX4 Q96LA9 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21628543 0.96 PTGER4 (0.43) PTGER4SMN1; SMN2PTGER2PPARGLTA4H
SCHEMBL21628804 0.93 PTGER4 (0.45) PTGER4SMN1; SMN2PTGER2PPARGLTA4H
SCHEMBL21628486 0.89 SMN1; SMN2 (0.40) PTGER4SMN1; SMN2LTA4HKCNH2SCN9A
SCHEMBL21628893 0.88 PTGER4 (0.45) PTGER4SMN1; SMN2PTGER2PPARGLTA4H
SCHEMBL21628645 0.87 SMN1; SMN2 (0.47) PTGER4SMN1; SMN2SCN9AMRGPRX4LMNA
SCHEMBL21628419 0.87 HDAC6 (0.42) PTGER4
SCHEMBL21628605 0.87 LMNA (0.47) PTGER4SMN1; SMN2MRGPRX4LMNA
SCHEMBL21628547 0.86 HPGD (0.43) PTGER4SMN1; SMN2SCN9ALMNA
SCHEMBL21628834 0.86 SMN1; SMN2 (0.40) PTGER4SMN1; SMN2SCN9ALMNA
SCHEMBL21628610 0.86 SMN1; SMN2 (0.39) PTGER4SMN1; SMN2LTA4HKCNH2SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600696-B2 Aromatic compounds Xeniopro GmbH (DE) 2026-04-14 US disclosed
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-12-21 US disclosed
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-05-18 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2022-11-03 US disclosed
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2021-04-15 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK PTGER4 4387/4885SMN1; SMN2 796/4885PTGER2 4323/4885
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK PTGER4 4387/4885SMN1; SMN2 796/4885PTGER2 4323/4885
US-11591289-B2 Aromatic compounds AHR, TYR, MUSK PTGER4 4252/4885SMN1; SMN2 1107/4885PTGER2 4166/4885
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK PTGER4 4387/4885SMN1; SMN2 796/4885PTGER2 4323/4885
US-12600696-B2 Aromatic compounds CCR1, CCRL2, AHR PTGER4 3926/4885SMN1; SMN2 919/4885PTGER2 3679/4885
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK PTGER4 4387/4885SMN1; SMN2 796/4885PTGER2 4323/4885
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK PTGER4 4387/4885SMN1; SMN2 796/4885PTGER2 4323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.